Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-019671

Director sold 5,000 shares at $85.76 ($428,800)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BEHRENS M KATHLEEN · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-10 Exercise or conversion : show line 1 in the form +5,000 $42.30 $211,500 135,517 D
2021-03-10 Sale : show line 2 in the form −5,000 $85.76 $428,800 130,517 D
Open-market sales · 5,000 sh · avg $85.76 · $428,800

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-10 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −5,000 0 D
Loading xslF345X03/doc4.xml…